XML 53 R38.htm IDEA: XBRL DOCUMENT v3.10.0.1
Geographic and Segment Information (Tables)
6 Months Ended
Jun. 30, 2018
Segment Reporting [Abstract]  
Revenue from External Customers by Geographic Areas
The table below presents net sales by operating segment and geographic region (in thousands):
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
 
2018
 
2017
 
2018
 
2017
Cardiopulmonary
 
 
 
 
 
 
 
 
United States
 
$
42,139

 
$
39,719

 
$
80,584

 
$
71,895

Europe
 
35,916

 
33,959

 
72,786

 
64,568

Rest of world
 
58,584

 
50,467

 
108,399

 
94,980

 
 
136,639

 
124,145

 
261,769

 
231,443

Heart Valves
 
 
 
 
 
 
 
 
United States
 
6,147

 
6,205

 
12,683

 
12,274

Europe
 
11,863

 
10,684

 
23,979

 
21,031

Rest of world
 
15,792

 
17,552

 
28,182

 
33,042

 
 
33,802

 
34,441

 
64,844

 
66,347

Advanced Circulatory Support
 
 
 
 
 
 
 
 
United States
 
5,468

 

 
5,468

 

Europe
 
353

 

 
353

 

Rest of world
 
194

 

 
194

 

 
 
6,015

 

 
6,015

 

Cardiac Surgery
 
 
 
 
 
 
 
 
United States
 
53,754

 
45,924

 
98,735

 
84,169

Europe
 
48,132

 
44,643

 
97,118

 
85,599

Rest of world
 
74,570

 
68,019

 
136,775

 
128,022

 
 
176,456

 
158,586

 
332,628

 
297,790

Neuromodulation
 
 
 
 
 
 
 
 
United States
 
89,395

 
81,405

 
167,387

 
155,064

Europe
 
11,943

 
9,514

 
22,234

 
17,443

Rest of world
 
9,315

 
6,096

 
14,876

 
11,667

 
 
110,653

 
97,015

 
204,497

 
184,174

 
 
 
 
 
 
 
 
 
Other
 
389

 
242

 
771

 
704

Totals
 
 
 
 
 
 
 
 
United States
 
143,149

 
127,329

 
266,122

 
239,233

Europe (1) (2)
 
60,075

 
54,157

 
119,352

 
103,042

Rest of world
 
84,274

 
74,357

 
152,422

 
140,393

Total (3)
 
$
287,498

 
$
255,843

 
$
537,896

 
$
482,668

(1)
Net sales include $8.4 million and $9.2 million in the United Kingdom, our country of domicile, for the three months ended June 30, 2018 and June 30, 2017, respectively. Net sales in the United Kingdom were $16.6 million and $17.3 million for the six months ended June 30, 2018 and June 30, 2017, respectively.
(2)
Europe sales include those countries in which we have a direct sales presence, whereas European countries in which we sell through distributors are included in Rest of world.
(3)
No single customer represented over 10% of our consolidated net sales and no country’s net sales exceeded 10% of our consolidated sales except for the U.S.
Schedule of Segment Reporting Information, by Segment
Operating income by segment is as follows (in thousands):
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
Operating Income from Continuing Operations
 
2018
 
2017
 
2018
 
2017
Cardiac Surgery
 
$
16,337

 
$
23,773

 
$
26,595

 
$
39,806

Neuromodulation
 
61,389

 
51,264

 
100,123

 
92,020

Other
 
(41,417
)
 
(33,037
)
 
(64,237
)
 
(49,903
)
Total reportable segment income from continuing operations
 
36,309

 
42,000

 
62,481

 
81,923

Merger and integration expenses
 
4,409

 
3,512

 
7,369

 
5,698

Restructuring expenses
 
476

 
2,597

 
2,357

 
12,627

Amortization of intangibles
 
9,817

 
8,116

 
18,618

 
16,076

Operating income from continuing operations
 
$
21,607

 
$
27,775

 
$
34,137

 
$
47,522


Assets by reportable segment (in thousands):
Assets
 
June 30, 2018
 
December 31, 2017
Cardiac Surgery
 
$
1,535,096

 
$
1,386,032

Neuromodulation
 
764,348

 
532,894

Other (1)
 
297,692

 
334,276

Discontinued operations
 

 
250,689

Total assets
 
$
2,597,136

 
$
2,503,891


(1)
Other includes the impact of ASU 2016-16. Refer to “Note 18. New Accounting Pronouncements.”
Capital expenditures by segment (in thousands):
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
Capital expenditures
 
2018
 
2017
 
2018
 
2017
Cardiac Surgery
 
$
4,594

 
$
3,957

 
$
7,725

 
$
7,751

Neuromodulation
 
500

 
517

 
847

 
1,978

Other
 
1,256

 
1,148

 
2,699

 
2,806

Discontinued operations
 

 
1,185

 
925

 
2,388

Total
 
$
6,350

 
$
6,807

 
$
12,196

 
$
14,923

Schedule of Goodwill
The changes in the carrying amount of goodwill by reportable segment for the six months ended June 30, 2018 were as follows (in thousands):
 
 
Neuromodulation
 
Cardiac Surgery
 
Other
 
Total
December 31, 2017
 
$
315,943

 
$
425,882

 
$
42,417

 
$
784,242

Goodwill as a result of acquisitions (1)
 
82,596

 
118,917

 

 
201,513

Foreign currency adjustments
 

 
(20,058
)
 

 
(20,058
)
June 30, 2018
 
$
398,539

 
$
524,741

 
$
42,417

 
$
965,697

(1)
Goodwill recognized as a result of the ImThera and TandemLife acquisitions. Refer to “Note 3. Business Combinations.”
Long-lived Assets by Geographic Areas
Property, plant and equipment, net by geography are as follows (in thousands):
PP&E
 
June 30, 2018
 
December 31, 2017
United States
 
$
64,298

 
$
62,154

Europe
 
111,045

 
119,133

Rest of world
 
10,813

 
11,072

Total
 
$
186,156

 
$
192,359